metricas
covid
Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) Cellular prion protein in the central nervous system of mammals. Anatomoclinical...
Journal Information
Vol. 25. Issue 4.
Pages 228-233 (January 2010)
Share
Share
Download PDF
More article options
Vol. 25. Issue 4.
Pages 228-233 (January 2010)
Original Article
Full text access
Cellular prion protein in the central nervous system of mammals. Anatomoclinical associations
La proteína priónica celular en el sistema nervioso central de mamíferos. Correlatos anatomoclínicos
Visits
1410
J.L. Velayos, A. Irujo
Corresponding author
airujo@unav.es

Corresponding author.
, M. Cuadrado-Tejedor, B. Paternain, F.J. Moleres, V. Ferrer
Departamento de Anatomía, Facultad de Medicina, Universidad de Navarra, Pamplona, Navarra, Spain
This item has received
Article information
Abstract
Introduction

The scrapie prion protein (PrPsc) requieres the celular prion protein (PrPc) for its propagation and replication. In this work we studied the expression and localization of the PrPc in the central nervous system (SNC) of the rat, mouse, cat, cow and human, using immunohistochemistry and Western blot techniques to understand more about prinopathies and Alzheimer's disease (EA).

Material and methods

For the immunohistochemistry study we used human, cat, rat and cow samples to analyse frontal, temporal and occipital cortex, as well as the hippocampus and the thalamus. For the Western blot analysis we used mouse, cat, cow and human brain samples.

Results

We observed a decrease in the amount of PrPc in the central nervous system (CNS) in a rostrocaudal shift in the species mentioned above. We observed inhibitory cells in the cat cortex. The Western blot analysis showed a similar pattern of expression in the different species studied with a preponderance of the diglycosylated band, in relation to the other bands observed in the analysis.

Discussion

These data suggest that in prionopathies PrPsc could be transmitted and could be replicated in and from the areas with most expression of PrPc. Similarly, a higher amount of this protein (PrPc) in some brain areas could explain some histopathological aspects of Alzheimer's disease (AD).

Conclusions

Our findings support the hypothesis of a retrograde transport of PrPsc in the CNS. PrPc could be related to the pathophysiology of AD.

Keywords:
Cellular prion protein
Prionopathies
Alzheimer's disease
Mammals
Resumen
Introducción

La proteína priónica celular patógena (PrPsc) necesita de la presencia de la fisiológica (PrPc) para su propagación y replicación. Se estudia comparativamente la expresión y localización de PrPc en el sistema nervioso central (SNC) de rata, ratón, gato, vaca y humano, mediante técnicas inmunohistoquímicas y de Western blot, con el objetivo de un mejor conocimiento de las prionopatías y de la enfermedad de Alzheimer (EA).

Material y métodos

Se emplearon encéfalos humanos y de gato, rata y vaca, para estudios por técnicas inmunohistoquímicas; se analizaron las cortezas frontal, temporal y occipital, así como hipocampo y tálamo. Se utilizaron técnicas de Western blot para encéfalos de ratón, gato, vaca y humano.

Resultados

Existe una disminución rostrocaudal de la cuantía de PrPc en el SNC de dichas especies. PrPc se sitúa en la membrana y en el citoplasma de las neuronas. Se observan neuronas inhibitorias en el córtex del gato. El patrón general del Western blot es análogo en las especies estudiadas, con predominio de la banda diglucosilada sobre las bandas monoglucosilada y no glucosilada.

Discusión

Los datos indican que en las prionopatías, PrPsc puede transmitirse y replicarse de forma retrógrada en y a partir de las zonas más PrP positivas. La mayor cuantía de PrPc en algunas zonas del encéfalo humano podría estar en relación con los hallazgos anatomopatológicos de la EA.

Conclusiones

Los datos apoyan un transporte retrógrado de la PrPsc en el SNC. La PrPc debe de tener relación con la fisiopatología de la EA.

Palabras clave:
Proteína priónica celular
Prionopatías
Enfermedad de Alzheimer
Mamíferos
Full text is only aviable in PDF
References
[1.]
P.E. Bendheim, H.R. Brown, R.D. Rudelli, J. Scala, N.L. Goller, G.Y. Wen, et al.
Nearly ubiquitous tissue distribution of the scrapie agent precursor protein.
Neurology, 42 (1992), pp. 149-156
[2.]
S. Brandner, A. Raeber, A. Sailer, T. Blattler, M. Fischer, C. Weissmann, et al.
Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system.
Proc Natl Acad Sci U S A, 93 (1996), pp. 13148-13151
[3.]
V. Manetto, R. Medori, P. Cortelli, P. Montagna, P. Tinuper, A. Baruzzi, et al.
Fatal familial insomnia: clinical and pathologic study of five new cases.
Neurology, 42 (1992), pp. 312-319
[4]
P. Gambetti, P. Parchi, R.B. Petersen, S.G. Chen, E. Lugaresi.
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features.
Brain Pathol, 5 (1995), pp. 43-51
[5]
A. Dorandeu, L. Wingertsmann, F. Chretien, M.B. Delisle, C. Vital, P. Parchi, et al.
Neuronal apoptosis in fatal familial insomnia.
Brain Pathol, 8 (1998), pp. 531-537
[6.]
J.L. Velayos, F. Alfageme.
Forebrain and brainstem perivascular neurons projecting to the thalamus (An anatomical explanation of the pathophysiology of fatal familial insomnia).
Eur J Anatomy, 3 (1997), pp. 87-92
[7.]
F.J. Moleres, J.L. Velayos.
The neurochemical nature of PrPccontaining cells in the rat brain.
Brain Research, 1174 (2007), pp. 143-151
[8.]
P. Parchi, R. Castellani, P. Cortelli, P. Montagna, S. Chen, R. Petersen, et al.
Regional distribution of protease-resistant prion protein in fatal familial insomnia.
Ann Neurol, 38 (1995), pp. 21-29
[9.]
P. Cortelli, D. Perani, P. Montagna, R. Gallassi, P. Tinuper, F. Provini, et al.
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18 FDG-PET studies.
Brain, 129 (2006), pp. 668-675
[10.]
J.L. Velayos, M. Oliva, F. Alfageme.
Afferent projections to the mediodorsal and anterior thalamic nuclei in the cat. Anatomicalclinical correlations.
Brain Pathol, 8 (1998), pp. 549-552
[11.]
J.L. Velayos, F.J. Moleres, M. Cuadrado, A.M. Irujo, B. Paternain.
Expresión y localización de la proteína priónica celular (PrPC) en el sistema nervioso central de la vaca. Algunas reflexiones sobre la nvCJD.
Neurologia, 21 (2006), pp. 421-427
[12.]
J.L. Velayos, A.M. Irujo, M. Cuadrado-Tejedor, B. Paternain, F. Moleres, V. Ferrer.
The cellular prion protein and its role in Alzheimer's disease.
Prion, 3 (2009), pp. 110-117
[13.]
F.J. Moleres, J.L. Velayos.
Expresion of PrPc in the rat brain and characterization of a subset of cortical neurons.
Brain Research, 1056 (2005), pp. 10-21
[14.]
F.J. Moleres, M. Castle, J.L. Velayos.
Expression of cellular prion protein (PrPc) in the rat central nervous system.
Eur J Anat, 7 (2003), pp. 85-90
[15.]
J.L. Velayos, J. Ullán, A. Amat, P. Ramos, J.A. Sieira, J.R. Sieira.
Expression of cellular prion protein (PrPc) in the cat central nervous system Some findings.
Eur J Anat, 6 (2002), pp. 23-29
[16.]
P. Rezai, C.C. Pontikis, L. Hudson, L.J. Cirns, P.L. Lantos.
Expression of cellular prion protein in the frontal and occipital lobe in Alzheimer's disease. Diffuse Lewy body disease, and normal brain: an immunohistochemical study.
J Histochem Cytochem, 53 (2005), pp. 929-940
[17.]
N.T. Watt, N.M. Hooper.
Prion protein in Alzheimer's disease.
Future Neurol, 2 (2007), pp. 587-590
[18.]
R.H. Nitsch, C. Hock.
Targeting beta-amyloid pathology in Alzheimer's disease with Abeta immunotherapy.
Neurotherapeutics, 5 (2008), pp. 415-420
[19.]
M. Cissé, L. Mucke.
Alzheimer's disease: a prion protein connection.
Nature, 457 (2009), pp. 1090-1091
[20.]
J. Koren, U.K. Jinwall, D.C. Lee, J.R. Jones, C.L. Shults, A.G. Johnson, et al.
Chaperone signalling complexes in Alzheimer's disease.
J Cell Mol Med, 13 (2009), pp. 619-630
Copyright © 2010. Sociedad Española de Neurología
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos